Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hartmann

Showing results (381-390 of 626) with videos related to

Pageof 63
Sort By:
Journal of Medicinal Chemistry|March 4, 2005
Synthesis and evaluation of (pyridylmethylene)tetrahydronaphthalenes/-indanes and structurally modified derivatives: potent and selective inhibitors of aldosterone synthaseSarah Ulmschneider, Ursula Müller-Vieira, Christian D Klein, et al.
Journal of Patient Safety|February 13, 2019
Nursing Home Senior Managers and Direct Care Staff: Are There Differences in Their Perceptions of Safety Climate?Emma D Quach, Lewis E Kazis, Shibei Zhao, et al.
European Journal of Medicinal Chemistry|September 27, 2014
Metabolic stability optimization and metabolite identification of 2,5-thiophene amide 17β-hydroxysteroid dehydrogenase type 2 inhibitorsEmanuele M Gargano, Enrico Perspicace, Nina Hanke, et al.
ACS Chemical Neuroscience|September 24, 2014
First selective dual inhibitors of tau phosphorylation and Beta-amyloid aggregation, two major pathogenic mechanisms in Alzheimer's diseaseMarica Mariano, Christian Schmitt, Parisa Miralinaghi, et al.
ACS Chemical Biology|February 17, 2016
Application of Dual Inhibition Concept within Looped Autoregulatory Systems toward Antivirulence Agents against Pseudomonas aeruginosa InfectionsAndreas Thomann, Antonio G G de Mello Martins, Christian Brengel, et al.
Journal of Medicinal Chemistry|June 24, 2010
Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigationSilvia Gobbi, Christina Zimmer, Federica Belluti, et al.
European Journal of Medicinal Chemistry|August 12, 2017
Drifting of heme-coordinating group in imidazolylmethylxanthones leading to improved selective inhibition of CYP11B1Silvia Gobbi, Qingzhong Hu, Christina Zimmer, et al.
Journal of Medicinal Chemistry|December 24, 2004
Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitorsFrancesco Leonetti, Angelo Favia, Angela Rao, et al.
Leukemia|April 1, 1988
Heterogeneity of insulin and insulin-like growth factor I binding in a human Burkitt type ALL cell line during the cell cycle and in three Burkitt type ALL sublinesW Hartmann, H Hitzler, J H Schlickenrieder, et al.
Journal of Medicinal Chemistry|January 26, 2016
Novel Strategies for the Treatment of Pseudomonas aeruginosa InfectionsStefanie Wagner, Roman Sommer, Stefan Hinsberger, et al.
Pageof 63

Showing results (381-390 of 626) with videos related to

Sort By:
Pageof 63
Journal of Medicinal Chemistry|March 4, 2005
Synthesis and evaluation of (pyridylmethylene)tetrahydronaphthalenes/-indanes and structurally modified derivatives: potent and selective inhibitors of aldosterone synthaseSarah Ulmschneider, Ursula Müller-Vieira, Christian D Klein, et al.
Journal of Patient Safety|February 13, 2019
Nursing Home Senior Managers and Direct Care Staff: Are There Differences in Their Perceptions of Safety Climate?Emma D Quach, Lewis E Kazis, Shibei Zhao, et al.
European Journal of Medicinal Chemistry|September 27, 2014
Metabolic stability optimization and metabolite identification of 2,5-thiophene amide 17β-hydroxysteroid dehydrogenase type 2 inhibitorsEmanuele M Gargano, Enrico Perspicace, Nina Hanke, et al.
ACS Chemical Neuroscience|September 24, 2014
First selective dual inhibitors of tau phosphorylation and Beta-amyloid aggregation, two major pathogenic mechanisms in Alzheimer's diseaseMarica Mariano, Christian Schmitt, Parisa Miralinaghi, et al.
ACS Chemical Biology|February 17, 2016
Application of Dual Inhibition Concept within Looped Autoregulatory Systems toward Antivirulence Agents against Pseudomonas aeruginosa InfectionsAndreas Thomann, Antonio G G de Mello Martins, Christian Brengel, et al.
Journal of Medicinal Chemistry|June 24, 2010
Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigationSilvia Gobbi, Christina Zimmer, Federica Belluti, et al.
European Journal of Medicinal Chemistry|August 12, 2017
Drifting of heme-coordinating group in imidazolylmethylxanthones leading to improved selective inhibition of CYP11B1Silvia Gobbi, Qingzhong Hu, Christina Zimmer, et al.
Journal of Medicinal Chemistry|December 24, 2004
Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitorsFrancesco Leonetti, Angelo Favia, Angela Rao, et al.
Leukemia|April 1, 1988
Heterogeneity of insulin and insulin-like growth factor I binding in a human Burkitt type ALL cell line during the cell cycle and in three Burkitt type ALL sublinesW Hartmann, H Hitzler, J H Schlickenrieder, et al.
Journal of Medicinal Chemistry|January 26, 2016
Novel Strategies for the Treatment of Pseudomonas aeruginosa InfectionsStefanie Wagner, Roman Sommer, Stefan Hinsberger, et al.
Pageof 63